DBV Technologies SA Sponsored ADR revenue breakdown overview

DBV Technologies SA Sponsored ADR revenue for the last year amounted to 4.20 M USD, the most of which — 4.15 M USD — came from its highest performing source at the moment, Epicutaneous Immunotherapy Products, the year earlier bringing 15.73 M USD. The greatest contribution to the revenue figure was made by France — last year it brought DBV Technologies SA Sponsored ADR 4.15 M USD, and the year before that — 15.73 M USD.